Mirabegron

CHEMBL2095212 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

396.5 g/mol

LogP

2.1

Phase

4

This medication relaxes the muscle in the bladder wall by activating specific receptors, reducing the urgency and frequency of urination. It is used to treat overactive bladder symptoms and is sometimes used in bladder cancer management.

الوزن الجزيئي

396,5000 g/mol

LogP

2,10

TPSA

129,00 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Ovarian Cancer Benign Prostatic Hyperplasia Cardiovascular Disease Pain Management Non-Small Cell Lung Cancer Parkinson's Disease Multiple Sclerosis Obesity Lymphoma Type 2 Diabetes Hypertension Breast Cancer Chronic Pain Heart Failure Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1

InChI

InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1

Molecular Formula

C21H24N4O2S

HBD / HBA

4 / 6

الروابط القابلة للدوران

9

الذرات الثقيلة

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This medication relaxes the muscle in the bladder wall by activating specific receptors, reducing the urgency and frequency of urination. It is used to treat overactive bladder symptoms and is sometimes used in bladder cancer management.

Yes, Mirabegron is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2095212. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9865528. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Mirabegron على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C21H24N4O2S
المرادفات: 1

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.